Physician profile
Benjamin T Oliver
NPI 1992202840
$5,289.61
in general payments reported to CMS, 2019-2025
34 companies · $545 in 2025
The $545 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $566 · 2022: $1,495 · 2023: $1,645 · 2024: $1,039 · 2025: $545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,210 · Education: $19.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,209.84 |
| Education | $19.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,514.48 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $628.81 | 2021-2024 | Xifaxan, Trulance, Plenvu |
| Janssen Biotech, INC. | $371.63 | 2021-2025 | Stelara, Simponi Aria, Simponi |
| Takeda Pharmaceuticals U.S.A., INC. | $363.53 | 2021-2025 | Entyvio, Gattex |
| Celgene Corporation | $359.20 | 2021-2024 | Zeposia |
| Pfizer INC. | $238.57 | 2023-2025 | |
| Janssen Scientific Affairs, LLC | $211.73 | 2022 | |
| Gilead Sciences, INC. | $204.68 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $201.04 | 2022-2025 | Dupixent |
| Genzyme Corporation | $151.95 | 2022-2024 | |
| Ironwood Pharmaceuticals, INC | $104.52 | 2022-2024 | Linzess |
| Mallinckrodt Hospital Products INC. | $97.33 | 2023 | Terlivaz |
| Ferring Pharmaceuticals INC. | $94.23 | 2021-2024 | Rebyota |
| Intercept Pharmaceuticals, INC. | $93.25 | 2022-2024 | Ocaliva |
| Ardelyx, INC. | $74.97 | 2023-2024 | Ibsrela |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $70.56 | 2022-2024 | Talicia |
| Nestle Healthcare Nutrition INC. | $61.56 | 2022-2023 | |
| Vivus LLC | $61.03 | 2022 | |
| Aimmune Therapeutics, INC. | $59.63 | 2025 | Zenpep |
| Phathom Pharmaceuticals, INC. | $42.58 | 2024 | Voquezna |
| Lilly USA, LLC | $36.69 | 2024 | Omvoh |
| E.R. Squibb & Sons, L.L.C. | $33.28 | 2022 | |
| Mauna Kea Technologies, INC. | $24.07 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $23.36 | 2022 | |
| Alnylam Pharmaceuticals INC. | $21.35 | 2022 | |
| Novo Nordisk INC | $20.38 | 2021 | |
| Celltrion USA INC. | $19.60 | 2024 | Zymfentra |
| Ambu INC. | $19.49 | 2023 | |
| Pharmacosmos Therapeutics INC. | $18.49 | 2023 | Monoferric |
| Boston Scientific Corporation | $15.13 | 2023 | Watchman Access System |
| Ethicon US, LLC | $14.46 | 2022 | |
| Intra-Sana Laboratories | $14.27 | 2021 | |
| Fresenius Kabi USA, LLC | $13.84 | 2023 | Idacio |
| Organon LLC | $9.92 | 2023 | Hadlima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Oliver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.